"Sutter Davis Hospital is a technologically advanced acute care hospital offering care for residents in Davis, Dixon, Winters, Woodland, West Sacramento, Vacaville and rural communities throughout Yolo and Eastern Solano counties. The Joint Commission recognizes this hospital as a Primary Stroke Center for their exceptional ability to provide high-quality stroke care."

During the past decade, Sutter Davis Hospital conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 44 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 41 clinical trials were completed. i.e. 315.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sutter Davis Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 43 trials, followed by "SWOG Cancer Research Network" with 22 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "GOG Foundation" with 6 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sutter Davis Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 47 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Agenus Inc." with 1 trials as a collaborator and "Association of American Medical Colleges" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Sutter Davis Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Invasive Breast Carcinoma" (6 trials), "Recurrent Ovarian Carcinoma" (6 trials) and "Cervical Adenocarcinoma" (5 trials). Many other conditions were trialed in "Sutter Davis Hospital" in a lesser frequency.

Most popular intervention types in "Sutter Davis Hospital" are "Drug" (71 trials), "Other" (61 trials), "Biological" (40 trials), "Procedure" (22 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (37 trials), "Quality-of-Life Assessment" (21 trials), "Computed Tomography" (13 trials), "Biospecimen Collection" (12 trials) and "Nivolumab" (12 trials). Other intervention names were less common.

The vast majority of trials in "Sutter Davis Hospital" are 65 trials for "All" genders, 26 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Sutter Davis Hospital". undefined are not yet recruiting, 16 are recruiting, 49 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Sutter Davis Hospital, 2 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Sutter Davis Hospital, 2 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".